Associate Professor Luke Grzeskowiak[/caption]
Professor Arduino Mangoni[/caption]
Neuropathic pain medicines can increase the risk of falls
These oft-used medicines have become the analgesia of choice for many prescribers. But care should be taken before prescribing gabapentinoids to certain patients.
Gabapentinoid medicines...
NSW pharmacies to offer COVID-19 vaccine to under-40s
About 450 community pharmacies in New South Wales will be able to administer the AstraZeneca COVID-19 vaccine to patients under 40 years of age from next week, the NSW Premier announced today.
Stepping down safely: deprescribing gabapentinoids in practice
Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.
Making antidepressant tapering safer and easier
In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.
How will post-lockdown restrictions impact pharmacists?
After more than 100 days in lockdown, New South Wales pharmacists reflect on the challenges of the past few months and what lies ahead.
Acute care opioid prescribing overhauled
A new standard of care will help to prevent long-term reliance on opioid analgesics used for acute pain.
